About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Scientists Develop Test Providing New Pathway for Identifying Obesity, Diabetes Drugs

by Kathy Jones on September 18, 2010 at 4:58 PM
Font : A-A+

 Scientists Develop Test  Providing  New Pathway for Identifying  Obesity,  Diabetes Drugs

A new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes has been developed by researchers at The Scripps Research Institute.

The new test, which the scientists call a simple assay, will allow researchers to look through hundreds of thousands of compounds for those that have potential to block the action of an enzyme known as ghrelin O-acyltransferase (GOAT).

Advertisement

"There hasn't been a simple screen until now," says Kim D. Janda, director of The Worm Institute for Research and Medicine at Scripps Research.

Ghrelin, a small peptide hormone that is mainly produced in the stomach, signals hunger, typically before meals.

Ghrelin has been associated with Prader-Willi syndrome, a common genetic cause of childhood obesity, in which patients have exceptionally high ghrelin levels.
Advertisement

The biology of ghrelin is quite intricate. For ghrelin to impact the body's metabolism, it must move from the stomach to the brain, where it acts on neurons.

GOAT acts as a "passport" check point station for the processing of 'pro-ghrelin.'

"Without GOAT's modification of 'pro-ghrelin,' ghrelin's entry into the brain, and thus its medicinal implications, are nullified," said Janda, a research associate.

"That's why GOAT has been coveted as a promising therapeutic target for obesity and diabetes," he added.

In developing their new approach, the team was inspired by enzyme immunoassay strategies commonly used in biology, chemistry, and medicine, and by "click chemistry," a concept developed at Scripps Research.

Because the amount of ghrelin modified by GOAT is minute, the scientists also used the principle of multi-turnover signal amplification for accurate detection.

In the end, the team succeeded in designing and creating the new technology-which they call "catalytic assay using enzyme-linked click chemistry assay" (cat-ELCCA).

"This new assay technology is both highly sensitive and reproducible," noted Janda, "making it an excellent assay for high-throughput screening."

The finding was published in an advance online early edition of the journal Angewandte Chemie on September 15, 2010.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetic Retinopathy Drug Toxicity Obesity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine 

Most Popular on Medindia

Pregnancy Confirmation Calculator Blood Donation - Recipients Find a Doctor Vent Forte (Theophylline) The Essence of Yoga Blood - Sugar Chart Find a Hospital Selfie Addiction Calculator Diaphragmatic Hernia Post-Nasal Drip
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Scientists Develop Test Providing New Pathway for Identifying Obesity, Diabetes Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests